This fact sheet discusses the risk groups who are more vulnerable to TB and why these groups are most at risk. The at-risk groups includeing the urban poor, migrants, and refugees, the homeless, prisoners, and people living with HIV/AIDS.
This website raises worldwide awareness about the international health threat posed by tuberculosis. For World TB Day 2005, the Stop TB Partnership Secretariat proposes to focus on the central role of frontline TB care providers in the fight against TB. It includes three Briefing Notes that the Stop TB Partnership Secretariat will distribute for planning and implementing advocacy and social mobilization activities for World TB Day 2005.
This brochure lists the differences between TB infection and TB disease. It discusses who should take a diagnostic test, the symptoms of TB, and provides a list of TB test sites in the San Francisco area.
This brochure lists the symptoms of active tuberculosis (TB) disease and includes directions for curing TB. It also provides drug information for treating TB and side effects that may occur from these medications.
This fact sheet presents data of the distribution on TB cases among the population of Los Angeles County in 2003.
This Briefing Note provides background and context for the frontline TB care providers theme of World TB Day 2005. Information on how to access global TB data and country profiles from the newly re-designed WHO TB website and a contact list of Regional and National coordinating partners of the Millennium Campaign are included.
This book is directed specifically to national TB control programs and their partners. It is intended to help select and implement the steps needed to ensure that the guiding principles of equity and poverty reduction are translated into practical measures - and that these practical measures are integrated into the national TB services and linked to broader poverty alleviation efforts.
This online fact sheet provides information about HIV/AIDS and TB co-infection.
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.
This report is the proceedings of the Tuberculosis Behavioral and Social Science Research Forum held on December 10-11, 2003 in Atlanta, GA. The Forum's goal was to identify and prioritize TB behavioral and social science research needs, so that a research agenda for TB prevention, control, and treatment could be developed. These Forum Proceedings include summaries of presentations and discussions, as well as a synthesis of research needs and priorities identified by attendees. For a hardcopy, contact the Communications, Education, and Behavioral Studies Branch at (404) 639-8135.
